Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study (original ) (raw )Dosing guidelines for fluconazole in patients with renal failure
Vincent Launay-vacher
Nephrology Dialysis Transplantation, 2003
View PDFchevron_right
Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study
Tobias Bingold
Infection and Drug Resistance, 2013
View PDFchevron_right
Empirical Fluconazole versus Placebo for Intensive Care Unit Patients
Susan McCormick Hadley
Annals of Internal Medicine, 2008
View PDFchevron_right
HPLC Assay of Fluconazole and Its Application to Patients with Early Septic Shock
Nouf Aloudah
Journal of Liquid Chromatography & Related Technologies, 2005
View PDFchevron_right
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid
Martin Mayers
Antimicrobial Agents and Chemotherapy, 1994
View PDFchevron_right
Average bioequivalence of two oral formulations of fluconazole in healthy subjects after multiple dosing Keywords average bioequivalence -fluconazole -multiple dosing -bioequivalence metrics -interindividual variability Received
Kristina Bozhinova
View PDFchevron_right
Pharmacokinetics of fluconazole in people with HIV infection: a population analysis
Andrew McLachlan
British Journal of Clinical Pharmacology, 2003
View PDFchevron_right
Pharmacokinetics of fluconazole in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration
Michael Roberts
International journal of antimicrobial agents, 2015
View PDFchevron_right
Bioequivalence of Two Oral Fluconazole Formulations in Healthy Subjects: a Single Dose, Open-Label, Randomized, Two-Period Crossover Study
Teresita Vargas Castro
Journal of Bioequivalence & Bioavailability, 2010
View PDFchevron_right
Co-administration of Fluoxetine Alters the Steady State Pharmacokinetics of Fluconazole after Multiple Oral Administration in Dogs
Iman Zaghloul
Scholarly Research Exchange, 2009
View PDFchevron_right
Fluconazole Loading Dose Pharmacokinetics and Safety in Infants
Lauren Piper
Pediatric Infectious Disease Journal, 2011
View PDFchevron_right
Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers
Chinedum P E A C E Babalola
Journal of Clinical Pharmacy and Therapeutics, 2009
View PDFchevron_right
A Review on Fluconazole
Navreet Kaur
Journal for Research in Applied Sciences and Biotechnology, 2023
View PDFchevron_right
Drug–drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatment
Erik Wilms
Journal of Antimicrobial Chemotherapy, 2023
View PDFchevron_right
Standardized susceptibility testing of fluconazole: an international collaborative study
B. Dupont
Antimicrobial Agents and Chemotherapy, 1992
View PDFchevron_right
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg
M. Hoffmann
Nephrology Dialysis Transplantation, 2005
View PDFchevron_right
Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration
Natasha Ornelas Lopez
Pharmacotherapy, 2014
View PDFchevron_right
Anidulafungin compared with fluconazole therapy in critically ill patients
Haran Schlamm
Critical Care, 2010
View PDFchevron_right
Pharmacokinetic study of intravenous posaconaozle in a critically ill patient with multiple organ failure
Porpon Rotjanapan
Australasian Medical Journal
View PDFchevron_right
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis
E. Tuomanen
Antimicrobial Agents and Chemotherapy, 1988
View PDFchevron_right
Gender Differences in the Oral Pharmacokinetics of Fluconazole
MIRIAM DEL CARMEN CARRASCO-PORTUGAL
Clinical Drug Investigation, 2007
View PDFchevron_right
Risk factors for subtherapeutic levels of posaconazole tablet
Lydia Benitez
Journal of Antimicrobial Chemotherapy
View PDFchevron_right
Pharmacokinetic study of intravenous posaconaozle in a critically ill patient with multiple organ failure: A case report
Porpon Rotjanapan
Australasian Medical Journal, 2017
View PDFchevron_right
In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis
Jeffrey Lipman
Antimicrobial Agents and Chemotherapy, 2015
View PDFchevron_right
Population Pharmacokinetics of Fluconazole in Young Infants
Ramasubbareddy Dhanireddy
Antimicrobial Agents and Chemotherapy, 2008
View PDFchevron_right
Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
Tyree Kiser
Annals of Clinical Microbiology and Antimicrobials
View PDFchevron_right
Bioequivalence evaluation of two formulations of fluconazole 150 mg capsule in healthy Arab men
Muhammad Hammami
Biopharmaceutics & Drug Disposition, 2005
View PDFchevron_right
Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers
Lei Ma
Antimicrobial Agents and Chemotherapy, 2009
View PDFchevron_right
Plasma Concentrations of Posaconazole Administered via Nasogastric Tube in Patients in a Surgical Intensive Care Unit
Stefan Höfer
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients
J. Kosterink
Antimicrobial Agents and Chemotherapy, 2021
View PDFchevron_right
Bicequivalence Evaluation of Two Formulations of Fluconazole 150 mg Capsule in Healthy Arab Men
Muhammad Hammami
View PDFchevron_right
Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*
Kevin Chung
Critical Care Medicine, 2005
View PDFchevron_right
Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects
Maria Caceres
Antimicrobial Agents and Chemotherapy, 2014
View PDFchevron_right
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients
Dr. Abdulaziz S Al Obaid
Antimicrobial Agents and Chemotherapy, 2016
View PDFchevron_right
The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans
Kaveh Zamani
Clinical Pharmacology & Therapeutics, 1993
View PDFchevron_right